Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is one of the seven known coronaviruses infecting humans; HKU1, 229E, NL63, OC43, Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, the last three of which can cause severe symptoms in patients. COVID-19, previously known as 2019 novel coronavirus, caused by SARS-CoV-2, was first reported in Wuhan, China, in late 2019, and quickly resulted in a major epidemic across the world. Although the origin of SARS-CoV-2 is not clear yet, genome sequencing results suggest that this is the third reported spillover of an animal coronavirus to humans, from 2002. The development of detection, therapeutic, and prevention strategies for COVID-19 is a fundamental task towards curing infected people and competing with the pandemic. Because of their similarities, scientists believe that treatment/ detection methods similar to what were used against the illnesses caused by SARS-CoV or MERS-CoV may be effective for curing/detecting COVID-19. Here, we review the recent nanotechnology techniques used for treating and testing SARS-CoV, MERS-CoV, and SARS-CoV-2, and potential therapeutic options for curing COVID-19. This patent summarizes the recent findings of advances on Nanotechnologies against Coronavirus.
Keywords: Nanotechnology, biomedicine, COVID-19, SARS-CoV-2, SARS-CoV, MERS-CoV.
Recent Patents on Nanotechnology
Title:Recent Patents and Advances on Nanotechnologies against Coronavirus
Volume: 15 Issue: 4
Author(s): Roozbeh Abedini-Nassab*Naeemeh Mahdaviyan
Affiliation:
- Department of Biomedical Engineering, University of Neyshabur, Neyshabur,Iran
Keywords: Nanotechnology, biomedicine, COVID-19, SARS-CoV-2, SARS-CoV, MERS-CoV.
Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is one of the seven known coronaviruses infecting humans; HKU1, 229E, NL63, OC43, Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and SARS-CoV-2, the last three of which can cause severe symptoms in patients. COVID-19, previously known as 2019 novel coronavirus, caused by SARS-CoV-2, was first reported in Wuhan, China, in late 2019, and quickly resulted in a major epidemic across the world. Although the origin of SARS-CoV-2 is not clear yet, genome sequencing results suggest that this is the third reported spillover of an animal coronavirus to humans, from 2002. The development of detection, therapeutic, and prevention strategies for COVID-19 is a fundamental task towards curing infected people and competing with the pandemic. Because of their similarities, scientists believe that treatment/ detection methods similar to what were used against the illnesses caused by SARS-CoV or MERS-CoV may be effective for curing/detecting COVID-19. Here, we review the recent nanotechnology techniques used for treating and testing SARS-CoV, MERS-CoV, and SARS-CoV-2, and potential therapeutic options for curing COVID-19. This patent summarizes the recent findings of advances on Nanotechnologies against Coronavirus.
Export Options
About this article
Cite this article as:
Abedini-Nassab Roozbeh *, Mahdaviyan Naeemeh , Recent Patents and Advances on Nanotechnologies against Coronavirus, Recent Patents on Nanotechnology 2021; 15 (4) . https://dx.doi.org/10.2174/1872210514666201110125536
DOI https://dx.doi.org/10.2174/1872210514666201110125536 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
Call for Papers in Thematic Issues
Advances in Vanadium and Titanium Resources for High-performance Materials via Nanostructuring and Nanoengineering (updated BMS-NANOTEC-2023-HT-31)
Vanadium and titanium-based materials are ideal candidates for structural and functional materials in aerospace, biomedical engineering, optics, catalysis, energy storage and conversion etc. Vanadium/titanium-based alloys, compounds and materials have a large family with different chemical compositions, dimensions, structures/morphologies, and chemical/physical/mechanical properties, which provides huge opportunities for the development of emerging ...read more
Endogenous- and exogenous-responsive nanocarriers for disease theranostics
Smart nanoplatforms with endogenous- and exogenous-responsiveness have been developed in biomedical applications, such as pH, redox, enzyme, hypoxia, light, ultrasound, radiation, electricity, magnetism, heat, etc. These smart nanocarriers can be effectively delivered by overcoming various barriers in vivo and achieve stimuli-responsive drug/gene release in targeted tissues, thus realizing the enhanced ...read more
Nanotechnology Emphasis on Novel Multifunctional Nanomaterials and Advanced Manufacturing for Applications in Science and Engineering
Nanotechnology and material science play key roles in the intrinsically multidisciplinary subject of Multifunctional Nanomaterials, Advanced Manufacturing, and Interfaces. Because of their unique qualities, these materials—which set them apart from their bulk counterparts—find use in a variety of industries, including aerospace, automotive, electronics, medical, energy, and materials engineering. They have ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System?
Current Medicinal Chemistry Regulation of Iron Absorption in Hemoglobinopathies
Current Molecular Medicine Respiratory Syncytial Virus Infection in Adult Populations
Infectious Disorders - Drug Targets Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters Advances in Heart Failure with Preserved Ejection Fraction Management - The Role of Sacubitril-Valsartan, Pirfenidone, Spironolactone and Empagliflozin: Is Success a Series of Small Victories?
Current Pharmaceutical Design Developing Novel Therapeutic Approaches to Frailty
Current Pharmaceutical Design Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature
Reviews on Recent Clinical Trials Approaches to the Management of Acute Kidney Injury in Children
Recent Patents on Biomarkers The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Current Rheumatology Reviews Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Strategies for Skeletal Muscle Targeting in Drug Discovery
Current Pharmaceutical Design The Role of HLA-Directed Antibodies in Cardiac Transplant Immunology
Current Cardiology Reviews A Review on Exploring Better Safety Prospects in Managing Cancer using Liposomal Combinations of Food Bioactive Compounds and Anticancer Drugs: Combisomes
Current Drug Delivery Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Management of Vasculopathy in Connective Tissue Disease
Current Rheumatology Reviews Mevalonate-Ras Homology (Rho)/Rho-Associated Coiled-Coil-Forming Protein Kinase (ROCK)-Mediated Signaling Pathway as a Therapeutic Target for the Treatment of Endometriosis-Associated Fibrosis
Current Signal Transduction Therapy Liverworts-Potential Source of Medicinal Compounds
Current Pharmaceutical Design Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery SARS-Coronavirus 2, A Metabolic Reprogrammer: A Review in the Context of the Possible Therapeutic Strategies
Current Drug Targets Aerosol Devices and Asthma Therapy
Current Drug Delivery